InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Pfeifer Andrea, 首席执行官. Officer active across 1 company, notably AC Immune SA. Aggregated, 2 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €53k. History available since 15 April 2026. The latest transaction was filed on 15 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Pfeifer Andrea
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
10,000 股@ US$3.14250.0094% mcap50.0% 占其流量ShareSEC:0001651625-26-000006:0
10,000 股@ US$3.14250.012% mcap33.3% 占其流量ShareSEC:0001651625-26-000005:0
标准退出：2026年7月14日 (T+90)
2 条申报中的 2 条
About Pfeifer Andrea
Andrea Pfeifer serves as the Chief Executive Officer of AC Immune SA. In this role, she is responsible for the strategic and operational leadership of the company. With a strong background in the biopharmaceutical sector, she plays a key role in developing new therapies and managing research and development operations. Her leadership is essential for AC Immune's growth and innovation.
